Siga Technologies SIGA
NASDAQ SIGA
$2.95 -0.15 (-4.98%)
At close: Aug 20, 2026 · 10:59 AM UTC

Siga Technologies (SIGA) Net Income towards Common Stockholders (2010 - 2025)

Siga Technologies' (SIGA) quarterly Net Income towards Common Stockholders came in at -$6.4 million in Q3 2025, down 573.67% YoY from $1.3 million in Q3 2024, and down 117.95% on a QoQ basis from $35.5 million in Q2 2025.

Siga Technologies (SIGA) Net Income towards Common Stockholders (2010 - 2025) Analysis & Trends

Siga Technologies (SIGA) has 16 years of Net Income towards Common Stockholders data on file, last reported at -$6.4 million in Q3 2025.

  • Quarterly Net Income towards Common Stockholders fell 573.67% year-over-year to -$6.4 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $28.7 million (down 51.44% YoY) and the FY2024 annual result came in at $59.2 million, down 13.01% from the prior year.
  • Net Income towards Common Stockholders eased to -$6.4 million in Q3 2025, from $35.5 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $73.4 million in Q4 2021 to a low of -$6.4 million in Q3 2025.
  • A 5-year average of $13.6 million and a median of -$258928.0 in 2021 frame the typical range for Net Income towards Common Stockholders.
  • Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders surged 9000.73% — and 2025, when it sank 573.67%.
  • Tracing SIGA's Net Income towards Common Stockholders over 5 years: stood at $73.4 million in 2021, then tumbled by 101.11% to -$811794.0 in 2022, then surged by 9000.73% to $72.3 million in 2023, then sank by 36.67% to $45.8 million in 2024, then sank by 113.91% to -$6.4 million in 2025.
  • The last three Net Income towards Common Stockholders figures came in at -$6.4 million (Q3 2025), $35.5 million (Q2 2025), and -$370415.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Haleon 43.81 Bn 42.84 Bn - -
2 Teva Pharmaceutical Industries 43.29 Bn 39.63 Bn 2.15 Bn -576.00 Mn
3 Zoetis 31.59 Bn 29.91 Bn 1.05 Bn 866.00 Mn
4 Takeda Pharmaceutical 28.67 Bn 22.88 Bn 5.10 Bn 710.19 Mn
5 United Therapeutics 22.24 Bn 19.58 Bn 683.80 Mn 333.00 Mn
6 Viatris 18.79 Bn 17.91 Bn 1.46 Bn -118.80 Mn
7 Neurocrine Biosciences 15.71 Bn 15.32 Bn 935.80 Mn 144.40 Mn
8 Elanco Animal Health 12.09 Bn 11.56 Bn 798.00 Mn 54.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - -
10 Siga Technologies 211.59 Mn 56.63 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -6.37 Mn
Jun 30, 2025 35.47 Mn
Mar 31, 2025 -370,415.00
Dec 31, 2024 45.76 Mn
Sep 30, 2024 1.34 Mn
Jun 30, 2024 1.80 Mn
Mar 31, 2024 10.28 Mn
Dec 31, 2023 72.26 Mn
Sep 30, 2023 -393,066.00
Jun 30, 2023 -2.88 Mn
Mar 31, 2023 -917,677.00
Dec 31, 2022 -811,794.00
Sep 30, 2022 33.04 Mn
Jun 30, 2022 1.99 Mn
Mar 31, 2022 -361,049.00
Dec 31, 2021 73.38 Mn
Sep 30, 2021 -3.11 Mn
Jun 30, 2021 -258,928.00
Mar 31, 2021 -1.73 Mn
Dec 31, 2020 20.16 Mn